This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignees: Synphar Laboratories, Inc., Taiho Pharmaceutical Company Limited, Syphar Laboratories, Inc.. Active years: 1995-1999.
Location History:
- Alberta, CA (1995)
- Edmonton, CA (1997 - 1999)
Company Filing History:
3 out of 21 
2 out of 320 
1 out of 1 Years Active: 1995-1999
Title: Andhe V Reddy: Innovator in Beta-Lactamase Inhibitors
Introduction
Andhe V Reddy is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit bacterial beta-lactamases. His work is crucial in enhancing the effectiveness of beta-lactam antibiotics against resistant bacterial strains.
Latest Patents
Andhe V Reddy holds 4 patents that focus on azetidinone derivatives as beta-lactamase inhibitors. His latest patents include innovative compounds such as 2-oxo-1-azetidine sulfonic acid derivatives. These compounds are designed to be potent inhibitors of bacterial beta-lactamases, which can be used in combination with beta-lactam antibiotics. This combination aims to increase the effectiveness of these antibiotics in treating infections caused by beta-lactamase producing bacteria.
Career Highlights
Throughout his career, Andhe V Reddy has worked with prominent companies in the pharmaceutical industry. He has been associated with Synphar Laboratories, Inc. and Taiho Pharmaceutical Company Limited. His expertise in drug development has led to advancements in antibiotic therapies.
Collaborations
Andhe has collaborated with esteemed colleagues such as Samarendra N Maiti and Ronald G Micetich. These collaborations have further enriched his research and development efforts in the field of pharmaceuticals.
Conclusion
Andhe V Reddy's contributions to the development of beta-lactamase inhibitors are significant in the fight against antibiotic resistance. His innovative work continues to impact the pharmaceutical industry positively.